PLC Systems Expands Into New Manufacturing Facility

PLC Systems Expands Into New Manufacturing Facility 


FRANKLIN, Mass., Oct. 22  /PRNewswire-FirstCall/ -- PLC Systems Inc. (AMEX:
PLC), a worldwide leader in cardiac laser technologies, today reported that it
has entered into an agreement to lease a clean room manufacturing facility in
Billerica, Massachusetts.  PLC intends to use the facility for the commercial
manufacturing of the disposable components for the Optiwave 980 Cardiac Laser
Ablation System.  The Optiwave 980 laser is manufactured in PLC's Franklin,
Massachusetts facility.

"This is an extraordinary opportunity for PLC to lease a world-class facility,
which includes a clean room for manufacturing processes and product assembly of
the Optiwave 980 disposable handpieces," stated Mark R. Tauscher, president and
CEO of PLC Systems.  "I expect that this facility will be tested and validated
in the fourth quarter.  We anticipate to be fully operational and in production
during the first quarter of 2005."

Tauscher continued, "Leasing this facility, which complements our stated growth
objective of expanding our product portfolio, is an important step for PLC. 
This decision is a result of the continued progress we are making in the
commercialization of the Optiwave 980.  After considering several options, we
concluded that the Billerica site meets our manufacturing expansion
requirements."

During the first quarter of this year, PLC Systems and Edwards Lifesciences
Corporation (NYSE:EW) announced that the two companies entered into an
exclusive, multi-year agreement to develop and manufacture Edwards' Optiwave
980 surgical ablation system.  Prior to the PLC and Edwards agreement, the
Optiwave 980 project was an ongoing program within Edwards. During 2004, the
research and development of the Optiwave 980 system was transitioned to PLC.

Tauscher concluded, "We are excited about the opportunities for the Optiwave
980 project.  Combined with our strategic alliance, current development
programs and our existing Franklin, Massachusetts site, this facility will play
an integral role in providing PLC with a strong foundation for growth.  This
expansion will create a number of technically-skilled jobs in the Commonwealth
of Massachusetts."

About PLC Systems Inc.

PLC Systems is a medical technology company specializing in innovative
technologies for the cardiac and vascular markets.  Currently, the company is
focused on two unique cardiac laser therapies.  Headquartered in Franklin,
Mass., PLC pioneered the CO2 Heart Laser System that cardiac surgeons use to
perform CO2 transmyocardial revascularization (TMR) to alleviate symptoms of
severe angina.  In addition, PLC is developing and manufacturing a surgical
cardiac ablation laser technology, known as the Optiwave 980, which is utilized
by surgeons to ablate cardiac tissue.  Additional company information can be
found at http://www.plcmed.com/.

This press release contains "forward-looking" statements. For this purpose, any
statements contained in this press release that relate to prospective events or
developments are deemed to be forward-looking statements.  Words such as
"believes," "anticipates," "plans," "expects," "will" and similar expressions
are intended to identify forward-looking statements.  Our statements of our
objectives are also forward looking statements.  While we may elect to update
forward-looking statements in the future, we specifically disclaim any
obligation to do so, even if our estimates change, and you should not rely on
these forward-looking statements as representing our views as of any date
subsequent to the date of this press release.  Actual results could differ
materially from those indicated by such forward-looking statements as a result
of a variety of important factors, including we may be unable to successfully
develop products under our new agreement with Edwards and Edwards may be
unsuccessful in distributing these products, operational changes, competitive
developments may affect the market for our products, regulatory approval
requirements may affect the market for our products, we may be unable to
convince health care professionals and third party payers of the medical and
economic benefits of the CO2 Heart Lasers and the Optiwave 980 System, and
there can be no assurance that all payers will reimburse health care providers
who perform TMR procedures or that reimbursement, if provided, will be
adequate, and additional risk factors described in our Report on Form 10-K for
the year ended December 31, 2003, and our other SEC reports.

PLC Systems, PLC Medical Systems, PLC and CO2 Heart Laser are trademarks of PLC
Systems Inc.

Edwards Lifesciences, Edwards, and Optiwave 980 are trademarks of Edwards
Lifesciences.

  Contact: John Jordan
           Director of Investor Relations
           508-541-8800, ext. 145


DATASOURCE: PLC Systems Inc.



CONTACT:  John Jordan, Director of Investor Relations of PLC Systems, +1-

508-541-8800, ext. 145



Web site:  http://www.plcmed.com/

Copyright